@

–òŠw•”@–òŠw‰È @
‹{è@ˆÇ“Þi ƒ~ƒ„ƒUƒL@ƒAƒ“ƒi j@1979”N3ŒŽ¶‚Ü‚ê@
Š‘®F –òŠw•”@–òŠw‰È E–¼F •‹³

Šw—ðEŽæ“¾ŠwˆÊ
@ 2001”N@‘åã–ò‰È‘åŠw@‘²‹Æ
2009”N@”ŽŽmi–òŠwjŽæ“¾i‘åã–ò‰È‘åŠwj
Žå‚ÈE—ð
@  
Š‘®Šw‰ï
@ “ú–{–òŠw‰ïA“ú–{ƒyƒvƒ`ƒhŠw‰ï
Žå‚ÈŒ¤‹†‰Û‘è
@ ERŽîᇊˆ«‚ð—L‚·‚éƒ\ƒ}ƒgƒXƒ^ƒ`ƒ“ƒAƒiƒƒO‚ÌŠJ”­Œ¤‹†
E‚c‚m‚`ƒ|ƒŠƒƒ‰[ƒ[‘jŠQŠˆ«•¨Ž¿‚Ì’Tõ
Žå‚ÈŒ¤‹†‹ÆÑ
@
E New Cyclic Somatostatin Analogues Containing a Pyrazinone Ring: Importance of Tyr for Antiproliferative Activity. A.Miyazaki, Y.Tsuda, S.Fukushima, T.Yokoi, T.Vántus, G.Bökönyi, E.Szabó, A.Horváth, G.Kéri and Y.Okada; Bioorg.Med.Chem.Lett.,18,6199-6201(2009).
E Synthesis of Somatostatin Analogues Containing C-Terminal Adamantane and Their Antiproliferative Properties. A.Miyazaki, Y.Tsuda, S.Fukushima, T.Yokoi, T.Vántus, G.Bökönyi, E.Szabó, A.Horváth, G.Kéri and Y.Okada; J.Med.Chem.,51,5121-5124(2008).
E Potent Dmt-Tic Pharmacophoric ƒÂ- and ƒÊ-Opioid Receptor Antagonists. T.Li, Y.Fujita, K.Shiotani, A.Miyazaki, Y.Tsuda, A.Ambo, Y.Sasaki, Y.Jinsmaa, E.Marczak, S.D.Bryant, S.Salvadori, L.H.Lazarus and Y.Okada; J.Med.Chem.,48,8035-8044(2005).
E Studies on the Mechanism of 1,2-Dihydropyrazin-2-one Ring Formation from Dipeptidyl Chloromethyl Ketone and Its Chemical Properties: Immediate Deamination during Catalytic Hydrogenation. A.Miyazaki, Y.Fujisawa, K.Shiotani, Y.Fujita, T.Li, Y.Tsuda, T.Yokoi, S.D.Bryant, L.H.Lazarus and Y.Okada; Chem.Pharm.Bull.,53(9),1152-1158(2005).
E Design and synthesis of novel type somatostatin analogs with antiproliferative activities on A431 tumorcells. A.Miyazaki, T.Yokoi, Y.Tachibana, R.Enomoto, E.Lee, G.Bökönyi, G.Kéri, Y.Tsuda and Y.Okada; Tetrahedron Lett.,45,6323-6327(2004).
Žå‚ȎЉ“®
@  
u‰‰‚ȂNj¦—͉”\‚ȃe[ƒ}‹y‚ÑŽÀÑ
@ Eƒyƒvƒ`ƒh‡¬A\‘¢Šˆ«‘ŠŠÖŒ¤‹†
‚»‚Ì‘¼
@  

£ƒy[ƒWTOP‚Ö–ß‚é

@